Control of immediate postoperative pain with topical bupivacaine hydrochloride for laparoscopic Falope ring tubal ligation

Article Abstract:

Female sterilization by tubal ligation involves tying off the fallopian tubes, through which the egg travels en route to the uterus. The surgeon generally inserts a band or clip around each fallopian tube under laparoscopic guidance (a fiberoptics tube inserted through a small incision in the abdominal wall). While mechanical methods such as these are safer than methods that rely on electrocoagulation (cautery), they can also lead to considerable postoperative pain. To evaluate the effectiveness of topical bupivacaine (an anesthetic) applied to the fallopian tubes, 64 patients were studied. They underwent bilateral Falope ring tubal ligation (a particular method) and were randomly assigned to receive one of four anesthetic treatments: no anesthetic (group A); bupivacaine applied to both tubes (group B); and bupivacaine applied to the right (group C) or left (group D) tube. Patients' pain levels were recorded at four intervals after surgery, ranging from shortly after the procedure to the morning of the following day. Results revealed that pain ratings were lower among group B than group A patients at the first and second rating periods, 15 minutes and 1 hour after surgery, respectively. Patients treated on only one side also reported less pain on that side at these times. Upon discharge from the hospital (three to five hours after ligation), no differences in pain ratings between groups A and B were seen, but patients treated on one side only said they had less pain on that side. These results were reflected in patients' requests for analgesic (pain-killing) medication. Bupivacaine, a long-acting anesthetic, appears to be a safe and effective agent for reducing postoperative pain after Falope ring tubal ligation. (Consumer Summary produced by Reliance Medical Information, Inc.)

Methods, Evaluation, Complications and side effects, Dosage and administration, Local anesthesia, Sterilization (Birth control), Sexual sterilization, Bupivacaine

---

Planned condom use among women undergoing tubal sterilization

Article Abstract:

Most women who undergo tubal sterilization plan on using condoms to protect themselves against sexually transmitted diseases. Researchers surveyed 2,782 women who had tubal sterilization over a six-year period. Only 11% said they would not use condoms after they were sterilized. Married women who used condoms regularly before sterilization were most likely to abandon them after sterilization. Women who were young, black, unmarried, had a history of sexually transmitted diseases or who had multiple sex partners were most likely to continue using condoms.

Usage, Surveys, Condoms, Tubal sterilization

---

Similar abstracts:

• Abstracts: Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET
• Abstracts: Quality of life before and after orthotopic hepatic transplantation
• Abstracts: Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. Gastroesophageal reflux as a pathogenic factor in the development of symptomatic lower esophageal rings
• Abstracts: Focal nodular hyperplasia of the liver associated with intracranial vascular malformations. Hepatic alcohol dehydrogenase activity in alcoholic subjects with and without liver disease
• Abstracts: Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.